Lotiglipron was discontinued in 2023 owing to unfavourable pharmacokinetic drug-drug interaction data from two Phase I studies and to elevated transaminases indicative of liver dysfunction in a subset of patients 24
Ipamorelin is a growth hormone-releasing peptide (GHRP), and some of the early research on animals is intriguingbut the studies are limited, and ipamorelin hasnt yet been approved for any medical use
Lagan AS, Rossetti P, Buscema M, La Vignera S, Condorelli RA, Gullo G, et al
In my research, I'm trying to create actually probiotic formulations that target these things and kill them through how we should be killing infections in our gut anyway versus just killing everything
This formulation utilizes liposomal technology to enhance absorption and efficacy, making it an ideal addition to a daily regimen